Trump’s Plan to Lower Drug Prices in U.S. Is Leading to Fewer New Drugs in Europe

An analysis shows that 27% fewer drugs launched in Europe since President Trump’s international drug-pricing policy began.
Read the full story on Hindustan Times Opens hindustantimes.com in a new tab
Advertisement
CallZenixAI Voice Bot, Dialer & IVR SolutionsCloud dialer and contact-center software for your teamKnow more
This is a short summary of a story published by Hindustan Times, shown with a link to the original. The full story, photo and reporting belong to Hindustan Times.











